CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer
Open accessPublished version of a preprint
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Immune checkpoint inhibitors (ICIs) have completely changed the approach pertaining to tumor diagnostics and treatment. Similarly, immunotherapy has also provided much needed data about mutation, expression and prognosis, affording an unprecedented opportunity for discovering candidate drug targets and screening for immunotherapy-relevant biomarkers. Although existing web tools enable biologists to analyze the expression, mutation and prognostic data of tumors, they are currently unable to facilitate data mining and mechanism analyses specifically related to immunotherapy. Thus, we effectively developed our own web-based tool, called Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancer (CAMOIP), in which we are able to successfully screen various prognostic markers and analyze the mechanisms involved in biomarker expression and function, as well as immunotherapy. The analyses include information relevant to survival analysis, expression analysis, mutational landscape analysis, immune infiltration analysis, immunogenicity analysis and pathway enrichment analysis. This comprehensive analysis of biomarkers for immunotherapy can be carried out by a click of CAMOIP, and the software should greatly encourage the further development of immunotherapy. CAMOIP provides invaluable evidence that bridges the information between the data of cancer genomics based on immunotherapy, providing comprehensive information to users and assisting in making the value of current ICI-treated data available to all users. CAMOIP is available at https://www.camoip.net.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz430 · Cited by 5,083
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Visualizing and interpreting cancer genomics data via the Xena platform
Goldman, M. J., Craft, B., Hastie, M., Repečka, K., McDade, F., Kamath, A., Banerjee, A., Luo, Y., Rogers, D., Brooks, A. N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0546-8 · Cited by 4,481
Cited by
Items 101–155 of 155
Wu, L., Sun, S., Song, P., Cong, C., Liu, N., Sun, M., & Zhao, W. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002846 · Cited by 1
MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSCPreprint
Ding, S., Duan, T., Yu, Y., Wu, H., Xu, Z., Yan, D., Meng, Q., Liu, Q., & Mu, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2142569/v1 · Cited by 1
CXCL13 Modulates Immunoactive Tumor Microenvironment and Improves Prognosis in Colorectal CancerPreprint
Guo, F., Chen, W., Yan, Y., Cui, Y., Peng, Y., Fang, J., Xuan, B., Hong, J., & Chen, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4195922
Xi, Y., Chen, B., Zeng, Y., Wei, L., Shao, Y.-C., Feng, M., & Zhang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2970917/v1
Self-citationLi, X., Li, X., Qin, J., Lei, L., Guo, H., Zheng, X., Wen, F., & Chen, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3479974/v1
[Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma].
Wang, J., Lu, L., He, X., Ma, L., Chen, T., Li, G., & Yu, H. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.101.25
Guo, F., Chen, W., Yan, Y., Yao, C., Zhang, R., Shen, C., Cui, Y., Peng, Y., Hong, J., Chen, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3667400/v1
Li, Y., Sheng, X., Dai, H., Wang, Y., Zhou, L., Yin, W., & Lu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3955629/v1
Multi‐omics analysis reveals inflammatory biomarkers for skin melanoma prognosis
Zhan, Z., Li, J., & Hu, X. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13172
“Spearman correlation analysis revealed a significant positive correlation between BIRC3 and MNDA, a weak negative correlation between ABCF1 and BIRC3, and no significant correlation between ABCF1 and MNDA (Figure 2d–f ) (Lin et al., 2022 ).”
BackgroundTIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes
Zhang, L., Huang, Y., Yang, Y., Liao, B., Hou, C., Wang, Y., Qin, H., Zeng, H., He, Y., Gu, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71421-3
KIFC1 is a potential therapeutic target and prognostic biomarker for renal papillary cell carcinomaPreprint
Chen, B., Zhang, W., He, J., Zhang, W., & Zou, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5341499/v1
Liu, S., Zhang, L., Yang, Y., Wang, L., Jiang, N., Li, J., & Zhang, M. (2025) · Medical Oncology · doi:10.1007/s12032-025-02841-y
“The analysis processes in Sangerbox [18], UALCAN [19], GEPIA2 [20], ACLBI (https:// www. aclbi. com/), Lnc2Can-cer 3.0 [21], TIDE [22], CAMOIP [23] and Kaplan ‒ Meier plotter [24] databases are the same as those used in our lat-est study [25].”
InfluentialOu, W., Zhou, J., Huang, Z., Yang, X., Liu, X., Zuo, W., Luo, Z., & Su, M. (2025) · Journal of Cancer · doi:10.7150/jca.117471
Xu, L., Lin, A., Li, Z., Shen, J., Chi, H., Wong, H. Z. H., Zhang, J., Wang, Q., Xu, J., Zhang, P., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01169-y
Self-citationHuang, J., Liu, C.-H., Chen, C.-R., Zhang, Q., Chen, Q., Qu, Y., & Chen, H. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0289
“The results obtained from the CAMOIP tool indicated that higher expression of GOLM1 is correlated with lower TMB and NAL in BRCA patients [39] (Figure 6A and B).”
SMAD4 May Serve as a Candidate Molecular Marker for Immune-Based Therapies Across Human Pan-Cancer
Liu, J., Lin, Y., Chen, X., & Huang, Z. (2025) · International Conference on Bioinformatics and Biomedical Technology (ICBBT) · doi:10.1109/icbbt65815.2025.11276658
Awasthi, S., Chaurasia, T. P., Verma, N., Chaturvedi, S., Kalani, A., Awasthi, S. K., Yadav, P. K., Singh, A., Singh, G., & Mishra, R. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201525
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622933
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622921
Mou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317759
Self-citationMou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317771
Self-citationLin, W., Yang, H., Lin, J., Yang, X., Liao, Z., Zheng, Y., Luo, P., & Liu, C. (2024) · Figshare · doi:10.6084/m9.figshare.25422416
Self-citationMou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317765
Self-citationLiu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622942
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622930
Lin, W., Yang, H., Lin, J., Yang, X., Liao, Z., Zheng, Y., Luo, P., & Liu, C. (2024) · Figshare · doi:10.6084/m9.figshare.26693976
Self-citationLi, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26061510
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622936
Mou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317762
Self-citationLi, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26061556
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622927
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622924
Lin, W., Yang, H., Lin, J., Yang, X., Liao, Z., Zheng, Y., Luo, P., & Liu, C. (2024) · Figshare · doi:10.6084/m9.figshare.25422327
Self-citationLiu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622945
Mou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317753
Self-citationMou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317768
Self-citationMou, W., Zhu, L., Yang, T., Lin, A., Lyu, Q., Guo, L., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2022) · Figshare · doi:10.6084/m9.figshare.20317756
Self-citationLin, W., Yang, H., Lin, J., Yang, X., Liao, Z., Zheng, Y., Luo, P., & Liu, C. (2024) · Figshare · doi:10.6084/m9.figshare.26693973
Self-citationLi, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26735955
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622939
Li, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26735958
Li, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26735952
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622948
Liu, D., Liu, Y., Zhu, W., Lu, Y., Zhu, J., Ma, X., Xing, Y., Yuan, M., Ning, B., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22622951
Li, H., Wu, J., Xu, Q., Pang, Y., Gu, Y., Wang, M., & Cheng, X. (2024) · Figshare · doi:10.6084/m9.figshare.26735949
Zeng, G., 吕国强, Hu, B., Xu, M., Li, G., Wang, M., Qiu, L., Zhang, R., Cheng, L., Xu, W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1765825
“To investigate whether CD160 , MERTK , and IL15 in fl uence speci fi c biological processes, we conducted Gene Ontology (GO) enrichment analysis using data from TCGA and the CAMOIP database (http://www.zjyy-oncology.com:20002/) in 373 STAD patients (35).”
Qian, S., Gong, H., Zhang, P., Pan, Y., Zhang, B., & Liu, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1766515
Zeng, G., 吕国强, Hu, B., Xu, M., Li, G., Wang, M., Qiu, L., Cheng, L., Zhang, R., Xu, W., et al. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70125
“To investigate whether FCER1A and PLCG2 influence specific biological processes, we conducted Gene Ontology (GO) enrichment analysis and Gene Set Enrichment Analysis (GSEA) using data from TCGA and the CAMOIP database (http://www. camoip.net/) in GC [45].”
Li, Y.-Y., Xing, A.-X., Li, W., Zhang, Y., Zhang, K., Xie, T.-H., Wu, G., & Zhang, W. (2026) · Biomedicines · doi:10.3390/biomedicines14061218 · Cited by 1
Xing, Y., Chu, Y., Zhu, W., Jing, F., Ma, X., Wang, Y., & Jia, Y. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05590-2
Xu, Q., Jiang, Y., Du, Q., Wang, J., Wang, C., & Qin, T. (2026) · Discover Oncology · doi:10.1007/s12672-026-05454-7
Han, Y., Zhang, M., Rehemujiang, M., Li, X., Liu, Y., Zhang, N., Sun, M., Zhang, Y., Hasim, A., & Li, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136040
Self-citationMuhammad, S. M., Wei, T., Iqbal, M. K., Jabbar, S., Akram, R., Bai, C., Liu, Y., & 崔晓楠 (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112907
Self-citationHu, W., Gao, Y., Li, Z., Du, Z., Tao, J., Politis, A. A., Grilli, F. V., Stefano, A. D., Wang, X., Zhang, J., et al. (2026) · Global Medical Genetics · doi:10.1016/j.gmg.2026.100127
Self-citationZhang, P., Han, Z., Wu, D., Zhang, H., He, J., Yang, Y., Fang, X., Gao, P., Wang, N., & Liu, S. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102477
Metadata
- Authors
- Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J.
- Affiliations
- Zhujiang Hospital (CN)
- Central South University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Luo, Peng
- Zhang, Jian
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-04-09
- Volume
- 23
- Issue
- 3
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W4225957066
- Semantic Scholar
- 112f9aa2b6cb6450112c3508adb1124e22c2697d
- Cited by
- 152
- References
- 51
- Citations by year
- 2026: 13 · 2025: 34 · 2024: 37 · 2023: 42 · 2022: 26
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Briefings in Bioinformatics (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Guangdong Province (2018A030313846, 2021A1515012593)
- Science and Technology Planning Project of Guangdong Province (2019A030317020)
- National Natural Science Foundation of China (81802257, 81871859, 81772457, 82172750, 82172811)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- immune checkpoint inhibitors, immunotherapy, pan-cancer, multi-omics integration, prognostic factors, immune cell infiltration, mutational landscape, immunogenicity, pathway enrichment, survival analysis, web server, cancer genomics
- MeSH terms
- Immune Checkpoint Inhibitors, Humans, Immunotherapy, Mutation, Neoplasms, Biomarkers, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.